AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie wholesaler Chargebacks — Beginning Balance ($M) ($M)
Form 10-K Item 7 MD&A Rebates & Chargebacks Rollforward
Latest, FY2025
1,157
Period ended Dec 31, 2025
Change on a year earlier
-1.3%
1,172 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AbbVie Wholesaler Chargebacks — Beginning Balance ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn_chargebacks_beg
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.